 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 01/19/2023 |
$2.35 |
$2.47 |
$2.24 |
$2.30 |
68.70K | | 01/20/2023 |
$2.30 |
$2.52 |
$2.18 |
$2.24 |
164.10K | | 01/23/2023 |
$2.22 |
$2.31 |
$2.10 |
$2.18 |
167.80K | | 01/24/2023 |
$2.20 |
$2.25 |
$2.01 |
$2.14 |
369.50K | | 01/25/2023 |
$2.17 |
$2.17 |
$2.04 |
$2.10 |
92.00K |
|
|
| AcelRx Pharmaceuticals is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Co.'s portfolio of products and product candidates consists of sufentanil sublingual products and product candidates, pre-filled syringe product candidates and nafamostat mesylate product candidates. Co.'s sufentanil sublingual products and product candidates include DSUVIA®, which is indicated for use in adults in supervised healthcare settings; Zalviso®, which is intended for the management of moderate-to-severe acute pain in hospitalized adult patients; and ARX-02, which is for cancer breakthrough pain in opioid-tolerant patients. | |
|
AcelRx Pharmaceuticals (ACRX) has the following price history information. Looking back at ACRX historical stock prices for the last five trading days, on January 19, 2023, ACRX opened at $2.35, traded as high as $2.47 and as low as $2.24, and closed at $2.30. Trading volume was a total of 68.70K shares. On January 20, 2023, ACRX opened at $2.30, traded as high as $2.52 and as low as $2.18, and closed at $2.24. Trading volume was a total of 164.10K shares. On January 23, 2023, ACRX opened at $2.22, traded as high as $2.31 and as low as $2.10, and closed at $2.18. Trading volume was a total of 167.80K shares. On January 24, 2023, ACRX opened at $2.20, traded as high as $2.25 and as low as $2.01, and closed at $2.14. Trading volume was a total of 369.50K shares. On January 25, 2023, ACRX opened at $2.17, traded as high as $2.17 and as low as $2.04, and closed at $2.10. Trading volume was a total of 92.00K shares.
ACRX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into AcelRx Pharmaceuticals shares, starting with a $10,000 purchase of ACRX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/29/2013 |
|
| End date: |
01/25/2023 |
|
| Start price/share: |
$106.60 |
|
| End price/share: |
$2.10 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-98.03% |
|
| Average Annual Total Return: |
-32.49% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$197.07 |
|
| Years: |
9.99 |
|
|
|
| Date |
Close |
| 01/19/2023 | $2.30 | | 01/20/2023 | $2.24 | | 01/23/2023 | $2.18 | | 01/24/2023 | $2.14 | | 01/25/2023 | $2.10 |
|
|
Free ACRX Email Alerts:
